Clinical trial
Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or…
NCT00406276 · Emory University, Other · Terminated
Key facts
| NCT number | NCT00406276 |
|---|---|
| Title | Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer |
| Official title | Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer |
| Lead sponsor | Emory University, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | RAD001, Docetaxel |
| Enrollment | 28 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Feb 1, 2013 |
| First posted | Dec 4, 2006 |
| Last update posted | Aug 23, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: